Martin Hrabĕ de Angelis Receives Paul Langerhans Medal 2021
The German Diabetes Society (DDG) awards its highest recognition, the Paul Langerhans Medal, to Martin Hrabĕ de Angelis. The society honors his outstanding achievements in research into the genetic and epigenetic factors of diabetes mellitus as well as his great contributions to the founding and development of the German Center for Diabetes Research (DZD). The internationally renowned laureate is research director at Helmholtz Zentrum München, board member of the DZD and Chair of Experimental Genetics at Technische Universität München.
As research director at Helmholtz Zentrum München, Martin Hrabĕ de Angelis heads the Institute of Experimental Genetics, which is part of the Helmholtz Diabets Center. In the course of his career, he discovered new genetic networks that may play a role in the pathogenesis of metabolic diseases such as diabetes. In this context, the development of databases and the application of modern data mining methods play an important role. Likewise, he and his colleagues discovered that obesity acquired through malnutrition as well as diabetes can be passed on epigenetically to offspring via both oocytes and sperm.
Martin Hrabĕ de Angelis has published over 550 original papers, which have been cited over 35,000 times, and is the author of several reference books. He leads research projects at the national and international level, has received numerous awards, and is one of the founders as well as spokesperson and board member of the German Center for Diabetes Research. Since 2018, he has been a member of the National Academy of Sciences, Leopoldina. At the same time, he is director of the European research consortium Infrafrontier, the world's first facility for systemic analysis of human disease models.
<link www.deutsche-diabetes-gesellschaft.de/die-ddg/ehrungen - extern>Learn more about the Paul Langerhans Medal</link>
<link ieg/index.html - extern>Visit Martin’s institute</link>